Skip to content
lifestyle.bossesmag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Clene Inc.
Clene Reports Second Quarter 2026 Financial Results and Recent Operating Highlights
August 14, 2026
Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval
August 12, 2026
Clene to Present at The Canaccord 46th Annual Growth Conference
July 29, 2026
Clene Reports First Quarter 2026 Financial Results and Recent Operating Highlights
May 30, 2026
Clene Announces $7 Million Underwritten Offering of Common Stock
May 28, 2026
Clene to Present at Upcoming May Conferences
May 28, 2026
After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS
May 28, 2026